๐๏ธ OncologyInjection (SC)
Epkinly
Epcoritamab
CD20-CD3 bispecific antibody administered subcutaneously for relapsed/refractory DLBCL.
Form
Injection (SC)
Uses
2
Side effects
5
Category
Oncology
01
What is Epkinly used for?
- Relapsed/refractory diffuse large B-cell lymphoma
- Large B-cell lymphoma
02
Epcoritamab side effects
The following side effects have been reported for Epcoritamab. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Fatigue
Injection site reactions
Musculoskeletal pain
ICANS
03
Epcoritamab warnings & precautions
- Black box: CRS and neurologic toxicity (ICANS)
- REMS program
- Step-up dosing required
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Epkinly in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.